This inventor holds 7 USPTO granted patents, plus 2 CIPO patents and 4 EPO patents. Top assignees: Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd., Tyco Electronics Technology (Sip) Co. Ltd., Te Connectivity Corporation. Active years: 2016-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Jiangsu, CN (2016 - 2018)
- Suzhou, CN (2019)
- Zhenjiang, CN (2019 - 2024)
Company Filing History:
5 out of 7 
2 out of 5 
1 out of 670 
Years Active: 2016-2024
Title: Jianghua Zhu: Innovator in Medicinal Chemistry
Introduction
Jianghua Zhu, an accomplished inventor based in Zhenjiang, China, has made significant contributions to the field of medicinal chemistry. With a total of seven patents to his name, Zhu focuses on innovations aimed at addressing conditions such as hyperuricemia and gout through his groundbreaking work on URAT1 inhibitors.
Latest Patents
Among his notable inventions are two latest patents related to URAT1 inhibitors. The first patent discloses a class of URAT1 inhibitor compounds, detailing their chemical structure alongside potential applications. Experimental results indicate that these compounds exhibit a significant inhibitory effect on hURAT1-transported uric acid in HEK293 transfected cells. This shows promising potential for treating hyperuricemia or gout. The second patent also focuses on URAT1 inhibitors aimed at promoting uric acid excretion. Similar to the first, these compounds are represented by a specific formula and have been proven effective in inhibiting uric acid transport, suggesting strong prospects for medicinal applications.
Career Highlights
Jianghua Zhu has worked at reputable companies, including Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. and Tyco Electronics Technology (SIP) Co., Ltd. His professional experience in these organizations has undoubtedly contributed to his expertise and innovative capabilities in the pharmaceutical sector.
Collaborations
Throughout his career, Zhu has collaborated with talented individuals such as Dongfang Shi and Xi Cheng. These partnerships have played a crucial role in fostering an environment of creativity and innovation, facilitating the development of his important patents.
Conclusion
Jianghua Zhu stands out as a prominent figure in the field of medicinal chemistry with his noteworthy inventions and collaborations. His work, particularly on URAT1 inhibitors, has significant implications for treating diseases related to uric acid levels. As he continues to innovate, Zhu's contributions will undoubtedly enhance our understanding and treatment of metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile